Lotte Steuten
Office of Health Economics
Lotte Steuten is listed as Office of Health Economics. Lotte is scheduled to speak at ISPOR Europe 2026 on 10 November 2026.
Compiled from published conference agendas; not yet confirmed by Lotte. Is this you? Claim this profile.
About
Lotte Steuten, PhD Deputy Chief Executive of the Office of Health Economics; former Member, Board of Directors, ISPOR Prof Lotte Steuten is deputy chief executive of the Office of Health Economics (OHE), the world’s oldest independent health economics research organization, based in London, UK, and a globally recognized expert in health economics and outcomes research (HEOR). Her research addresses challenges in valuing and paying for innovative therapies, with the aim of achieving effective, accessible, affordable, and efficient healthcare for all. She has published over 150 peer-reviewed papers on topics including the value of novel treatments, diagnostics and prevention for a wide range of non-communicable and infectious diseases. With 2 decades of experience across Europe, the United States, and Asia Pacific, she advises governments, industry, and other organizations worldwide. She is frequently sought by media and international stakeholders for expert commentary on HEOR, value ass
Upcoming
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Convergence and the Transatlantic Bargain: US Pricing Reform, the EU Pharma Package, and What Either Means for Innovation and Access Speaker · 10 November 2026
- Could a Higher Willingness-to-Pay for 'Innovative' Therapies in Cost Effectiveness HTAs Help Enable Europe to Retain R&D and Manufacturing? Speaker · 10 November 2026
- Opportunity Cost, or Opportunity Lost? Sacred Principle, Functional Fiction, or Evolving Concept in HTA? Speaker · 10 November 2026
- Shaping the Global Research and Policy Agenda in HEOR in the Next Decade: A Value in Health Regional Issues Forum Speaker · 10 November 2026
World EPA Congress Europe 2027 2 March 2027 – 3 March 2027
- Navigating Market Access & Joint Clinical Assessment (JCA) Speaker · 2 March 2027
- EU HTA Regulation: Towards Timelier Population Access to Vaccination? Panellist · 3 March 2027